Table 5.
Additional subgroup analyses for preterm birth prior to 37 and 34 weeks*
17-OHP (N=327) |
Placebo (N=330) |
RR (95% CI) | P** | |
---|---|---|---|---|
Preterm birth < 37 weeks | ||||
Cervical length | 0.59 | |||
< 10 mm | 5/9 (55.6) | 10/16 (62.5) | 0.89 (0.44 – 1.78) | |
10–20 mm | 19/50 (38.0) | 18/40 (45.0) | 0.84 (0.52 – 1.38) | |
> 20 mm | 58/268 (21.6) | 52/274 (19.0) | 1.14 (0.82 – 1.59) | |
Preterm birth < 34 weeks | ||||
Cervical length | 0·82 | |||
< 15 mm | 9/25 (36·0) | 13/31(41.9) | 0·86 (0·44–1·67) | |
≥15 mm | 32/302 (10.6) | 35/299 (11.7) | 0.91 (0·58–1·42) | |
Cervical length | 0·49 | |||
< 10 mm | 5/9 (55·6) | 6/16 (37·5) | 1.48 (0·63–3.51) | |
10–20 mm | 11/50 (22·0) | 12/40 (30·0) | 0·73 (0·36–1·48) | |
> 20 mm | 25/268 (9.3) | 30/274 (10.9) | 0·85 (0·52–1·41) |
Data presented as n/N (%)
P value for Breslow-Day interaction term